Coloplast A/S/DKr COLO B
08:00
10:00
12:00
13:55
15:55
1D1W1MYTD1Y5YMAX
About Coloplast A/S
Coloplast A/S is a Danish company specializing in the development and manufacturing of medical devices and services. Its core business operates within the healthcare industry, focusing on products for ostomy care, continence care, wound and skin care, and urology. Founded in 1957, the company has a significant history of innovation in personalized healthcare products. Headquartered in Humlebæk, Denmark, Coloplast serves a global market, ensuring strong geographic diversification. The company is strategically positioned with strengths in customer-centric product development and a robust distribution network, enhancing its competitive advantage in the medical devices sector.
Ticker
DKr COLO B
Sector
Primary listing
CSE
Employees
16,744
Headquarters
Humlebæk, Denmark
Website
Coloplast A/S Metrics
BasicAdvanced
kr 123B
33.92
kr 16.13
0.62
kr 23.00
4.20%
Price and volume
Market cap
kr 123B
Beta
0.62
52-week high
kr 776.40
52-week low
kr 535.00
Average daily volume
311K
Dividend rate
kr 23.00
Financial strength
Current ratio
1.607
Quick ratio
0.941
Long term debt to equity
124.358
Total debt to equity
140.423
Dividend payout ratio (TTM)
136.36%
Interest coverage (TTM)
10.25%
Profitability
EBITDA (TTM)
8,630
Gross margin (TTM)
67.97%
Net profit margin (TTM)
13.04%
Operating margin (TTM)
27.70%
Effective tax rate (TTM)
40.95%
Revenue per employee (TTM)
kr 1,660,000
Management effectiveness
Return on assets (TTM)
10.01%
Return on equity (TTM)
21.35%
Valuation
Price to earnings (TTM)
33.924
Price to revenue (TTM)
4.425
Price to book
7.65
Price to tangible book (TTM)
-9.09
Price to free cash flow (TTM)
23.637
Free cash flow yield (TTM)
4.23%
Free cash flow per share (TTM)
23.15
Dividend yield (TTM)
4.20%
Growth
Revenue change (TTM)
3.12%
Earnings per share change (TTM)
-28.18%
3-year revenue growth (CAGR)
7.27%
10-year revenue growth (CAGR)
7.20%
3-year earnings per share growth (CAGR)
-9.98%
10-year earnings per share growth (CAGR)
14.40%
3-year dividend per share growth (CAGR)
4.77%
10-year dividend per share growth (CAGR)
11.14%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Coloplast A/S stock?
Coloplast A/S (COLO B) has a market cap of DKr123B as of January 22, 2026.
What is the P/E ratio for Coloplast A/S stock?
The price to earnings (P/E) ratio for Coloplast A/S (COLO B) stock is 33.92 as of January 22, 2026.
Does Coloplast A/S stock pay dividends?
Yes, the Coloplast A/S (COLO B) stock pays dividends to shareholders. As of January 22, 2026, the dividend rate is DKr23 and the yield is 4.2%. Coloplast A/S has a payout ratio of 136.36% on a trailing twelve-month basis.
When is the next Coloplast A/S dividend payment date?
The next Coloplast A/S (COLO B) dividend payment date is unconfirmed.
What is the beta indicator for Coloplast A/S?
Coloplast A/S (COLO B) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.